Anitox is pleased to announce the appointment of Dr Alan Doyle as Commercial Director of its fast-growing Asia Pacific operation. Dr Doyle will lead the team responsible for delivering high-value Finio™ and Termin-8® pathogen control and Maxi-Mil® feed milling efficiency programs to breeder, layer, broiler and feed milling operations throughout the region.
Dr Doyle is a qualified veterinarian and graduate of Glasgow Veterinary School in the United Kingdom. He has been associated with the animal health industry for more than 30 years, serving market-leading operations including Beecham, Pfizer (Zoetis) and Ceva. He has an impressive track record driving profitable growth in senior commercial and business leadership roles, and returns to Anitox where he held a commercial management role in its EMEA team from 2009 and 2012.
“With Dr Doyle’s extensive experience and technical bias, Anitox can deliver on its commitment to continuously improve our market-leading service and support in Asia’s rapidly developing animal feed industry,” said Anitox Chief Operating Officer Roger Mann. “I am delighted to welcome him back to the Anitox team.”
Dr Doyle and his family will be based in Kuala Lumpur, Malaysia. He can be contacted at firstname.lastname@example.org